Sun Pharmaceutical Industries Share Price Today - Live Blog for September 01, 2025

Sun Pharmaceutical Industries Ltd's stock has surged by 0.12%, and it is currently trading at ₹1,564.20. Additionally, the stock maintains a PE ratio of 36.8700, while the industry PE is 34.3368.

Following a noteworthy 0.11% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,564.00. When it comes to valuation, this stock has a PE ratio of 36.8700, with the industry PE ratio at 34.3368.

With a -0.04% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,562.95. Investors should examine the factors driving this decline. The stock's PE ratio is 36.8700, whereas the industry PE ratio stands at 34.3368.

After a -0.04% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,563.50. The stock has a PE ratio of 36.8700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.13% upswing, and it's currently trading at ₹1,563.75 per share. Investors are closely watching this development.

After a -0.09% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,561.85. The stock has a PE ratio of 36.8700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.09%, reaching the current market price of ₹1,563.25. This surge is indicative of the stock's recent positive performance.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.07%, reaching the current market price of ₹1,561.95. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.06% gain, with the share price now at ₹1,561.40. Notably, the stock's PE ratio stands at 36.8700, and its Return on Equity (ROE) is 15.1334%.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.04% decline and is currently trading at ₹1,559.90 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.05% in its share price, and it currently trades at ₹1,560.00 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

With a -0.08% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,560.80. Investors should examine the factors driving this decline. The stock's PE ratio is 36.8700, whereas the industry PE ratio stands at 34.3368.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.13%. At this moment, it's actively trading at ₹1,562.05, presenting an enticing opportunity for those in the market.

Sun Pharmaceutical Industries Ltd witnessed a -0.74% decrease in its share price, and it is currently trading at ₹1,571.45. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 36.8700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a -0.74% drop in its share price and is currently trading at ₹1,571.45. With the stock's PE at 36.8700 and the industry PE at 34.3368, investors are weighing their options.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.04% uptick, and they are currently valued at ₹1,583.20, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.13%, a situation worth noting. At present, the stock is trading at ₹1,582.65. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 36.8700, while the industry PE ratio is 34.3368.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.12% upswing, and it's currently trading at ₹1,584.70 per share. Investors are closely watching this development.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.05% upswing, and it's currently trading at ₹1,582.85 per share. Investors are closely watching this development.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.20%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,585.35, and market participants are assessing the implications. The stock has a PE ratio of 36.8700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd experienced a -0.28% dip in its share price and is currently trading at ₹1,588.00. The stock has a PE ratio of 36.8700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.07%, reaching the current market price of ₹1,592.40. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd share price surged by 0.30%. With its current market price standing at ₹1,593.10 per share, this stock is garnering increased attention from the investment community.

Sun Pharmaceutical Industries Ltd experienced a -0.21% dip in its share price and is currently trading at ₹1,587.65. The stock has a PE ratio of 36.8700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a -0.77% drop in its share price and is currently trading at ₹1,592.70. With the stock's PE at 36.8700 and the industry PE at 34.3368, investors are weighing their options.